Bismuth Subsalicylate Oral Suspension from China
A liquid mixture containing bismuth subsalicylate as the active ingredient, combined with inorganic suspending agents, used for treating upset stomach, diarrhea, and heartburn. It falls under HTS 3824.99.31.00 as a mixture of two or more inorganic compounds of bismuth not elsewhere specified, specifically formulated for pharmaceutical use.
Duty Rate — China → United States
44%
Rate breakdown
9903.05.3112.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of China, as provided for in U.S. note 52 to this subchapter
9903.88.0325%Except as provided in headings 9903.88.13, 9903.88.18, 9903.88.33, 9903.88.34, 9903.88.35, 9903.88.36, 9903.88.37, 9903.88.38, 9903.88.40, 9903.88.41, 9903.88.43, 9903.88.45, 9903.88.46, 9903.88.48, 9903.88.56, 9903.88.64, 9903.88.66, 9903.88.67, 9903.88.68, or 9903.88.69, articles the product of China, as provided for in U.S. note 20(e) to this subchapter and as provided for in the subheadings enumerated in U.S. note 20(f)
Import Tips
• Verify exact bismuth compound composition to confirm classification under 3824.99.31.00; pharmaceutical mixtures may require FDA registration and drug import alerts
• Include certificates of analysis showing inorganic bismuth content and ensure labeling complies with US pharmacopeia standards to avoid CBP reclassification